Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma.

Cancers (Basel) · 2020 · PMC7699209 · PMID 33218185

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although homozygous NKG2C deletion ( NKG2C −/− ) frequency was two-fold higher in B-NHL patients (4.5%) than in healthy controls (1.6%), this finding, however, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.